Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0812 | 0.8164 | 0.8147 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0952 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0798 | 0.7967 | 0.7967 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0952 | 1 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0952 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0952 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.1652 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0514 | 0.4222 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0757 | 0.743 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0514 | 0.4222 | 0.4171 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0758 | 0.7441 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.1652 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0708 | 0.6782 | 0.6753 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0952 | 1 | 0.5 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0445 | 0.3309 | 0.1985 |
Loa Loa (eye worm) | hypothetical protein | 0.0201 | 0.0087 | 0.0087 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0757 | 0.743 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0708 | 0.6782 | 0.6753 |
Loa Loa (eye worm) | hypothetical protein | 0.0492 | 0.3934 | 0.3934 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0952 | 1 | 1 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0445 | 0.3309 | 0.1985 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0757 | 0.743 | 0.7408 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0952 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0255 | 0.081 | 0.0729 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.1652 | 0.1579 |
Loa Loa (eye worm) | hypothetical protein | 0.0424 | 0.3032 | 0.3032 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0513 | 0.4212 | 0.4161 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 0.3309 | 0.3309 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.045 | 0.338 | 0.207 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0952 | 1 | 0.5 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0952 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0708 | 0.6782 | 0.6753 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0758 | 0.7441 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.1652 | 0.1579 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0952 | 1 | 1 |
Brugia malayi | gamma-aminobutyric-acid receptor beta subunit precursor | 0.0492 | 0.3934 | 0.2733 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0952 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0319 | 0.1652 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0513 | 0.4212 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0569 | 0.4945 | 0.4901 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0563 | 0.4871 | 0.4826 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0445 | 0.3309 | 0.1985 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0708 | 0.6782 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0708 | 0.6782 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0513 | 0.4212 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0757 | 0.743 | 0.7408 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0952 | 1 | 1 |
Giardia lamblia | GTOR | 0.0952 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0638 | 0.5865 | 0.5829 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0708 | 0.6782 | 0.6753 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0319 | 0.1652 | 0.1652 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0514 | 0.4222 | 0.4171 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0952 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0618 | 0.5594 | 0.5555 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0757 | 0.743 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0563 | 0.4871 | 0.4826 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0952 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0569 | 0.4945 | 0.4901 |
Loa Loa (eye worm) | hypothetical protein | 0.0227 | 0.044 | 0.044 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0514 | 0.4222 | 0.4171 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.0445 | 0.3309 | 0.1985 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0758 | 0.7441 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0708 | 0.6782 | 0.6753 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0952 | 1 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0708 | 0.6782 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0569 | 0.4945 | 0.4901 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0395 | 0.2657 | 0.1204 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | > 8000 nM | Binding affinity at dopamine receptor D3 | ChEMBL. | 11543687 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.